Venetoclax combined with low dose cytarabine compared to standard of care intensive chemotherapy for the treatment of favourable risk adult acute myeloid leukaemia (VICTOR): Study protocol for an…

Overview of attention for article published in BMC Cancer, November 2022

Altmetric Badge

About this Attention Score

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 25,965 followers.

RT @ISRCTN: Venetoclax with low-dose cytarabine compared to standard-of-care intensive chemotherapy for favourable risk adult acute myeloid…

Venetoclax with low-dose cytarabine compared to standard-of-care intensive chemotherapy for favourable risk adult acute myeloid leukaemia Read the protocol for the VICTOR study in #BMCCancer @BMC_series #ClinicalTrials #ISRCTN: https://t.co/rsabUtTkWZ ht

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.